Thank you, Mr. Berthold.
First, despite all the supply and approval challenges, Canada is among the top four countries in the world when it comes to the regulation and procurement of Paxlovid.
That said, as you also pointed out, this drug must be prioritized for the most vulnerable people. You listened carefully and accurately summarized the conversation that took place yesterday at the press conference.
Clinicians, doctors and nurses in every province and territory are doing this work as of today, since the treatment has been in the country for a few days.